Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Immunohistochemical expression of p53, ki-67, tenascin, and fibronectin in giant cell fibroma and traumatic fibroma of the oral mucosa

View through CrossRef
Objective: This study aimed to compare the immunoexpression of p53, ki-67, tenascin, and fibronectin between giant cell fibroma (GCF) and traumatic fibroma (TF), in order to explore a benign neoplastic or a reactive nature of GCF. Methods: A cross-sectional study was conducted. Samples of GCF and TF were retrieved from the files of Oral Pathology Service, matched by site and size. Immunohistochemistry for p53, ki-67, tenascin, and fibronectin was evaluated in the superficial and deep regions of the lesions using the Image J Software. The number of positive cells was determined for p53 and ki-67, and the positive area was established for tenascin and fibronectin. Statistical analysis was performed with Mann-Whitney and independent t-tests (p≤0.05).  Results: Comparing to TF, GCF showed higher expression of p53 protein in superficial (p=0.009) and deep regions (p=0.027), as well as higher tenascin expression in deep regions (p=0.000). Ki-67 and fibronectin immunoexpression did not differ between GCF and TF (p>0.05). Conclusions: The results of the present study seem supportive of a benign neoplastic nature of GCF, rather than a reactive one, especially considering the p53 and tenascin expression. Further studies with larger samples and broader markers should confirm this hypothesis.
Title: Immunohistochemical expression of p53, ki-67, tenascin, and fibronectin in giant cell fibroma and traumatic fibroma of the oral mucosa
Description:
Objective: This study aimed to compare the immunoexpression of p53, ki-67, tenascin, and fibronectin between giant cell fibroma (GCF) and traumatic fibroma (TF), in order to explore a benign neoplastic or a reactive nature of GCF.
Methods: A cross-sectional study was conducted.
Samples of GCF and TF were retrieved from the files of Oral Pathology Service, matched by site and size.
Immunohistochemistry for p53, ki-67, tenascin, and fibronectin was evaluated in the superficial and deep regions of the lesions using the Image J Software.
The number of positive cells was determined for p53 and ki-67, and the positive area was established for tenascin and fibronectin.
Statistical analysis was performed with Mann-Whitney and independent t-tests (p≤0.
05).
  Results: Comparing to TF, GCF showed higher expression of p53 protein in superficial (p=0.
009) and deep regions (p=0.
027), as well as higher tenascin expression in deep regions (p=0.
000).
Ki-67 and fibronectin immunoexpression did not differ between GCF and TF (p>0.
05).
Conclusions: The results of the present study seem supportive of a benign neoplastic nature of GCF, rather than a reactive one, especially considering the p53 and tenascin expression.
Further studies with larger samples and broader markers should confirm this hypothesis.

Related Results

Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in ...
Abstract 422: Novel approach to destabilization of oncogenic mutant p53 and therapeutic implications
Abstract 422: Novel approach to destabilization of oncogenic mutant p53 and therapeutic implications
Abstract Introduction: Mutant p53 drives several hallmarks of cancer through a gain-of-function oncogenic program. The oncogenicity of mutant p53 includes sustained ...
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
The AP-1 protein complex primarily consists of several proteins from the c-Fos, c-Jun, activating transcription factor (ATF), and Jun dimerization protein (JDP) families. JDP2 has ...
The Complex Interplay Between p53 and Aneuploidy in Cancer
The Complex Interplay Between p53 and Aneuploidy in Cancer
In this thesis, we dived into the complex relationship between p53 and aneuploidy. p53 acts as a central tumor suppressor that responds to diverse cellular stresses, including DNA ...
Abstract 1262: Depletion of dominant-negative mutant p53 improves the efficacy of mutant p53 reactivators.
Abstract 1262: Depletion of dominant-negative mutant p53 improves the efficacy of mutant p53 reactivators.
Abstract TP53 (p53) forms a tetramer and functions as a transcription factor to upregulate mRNA expression of genes involved in cell cycle progression and apoptos...

Back to Top